Cardiovascular diseases, including stroke and myocardial infarction, are the world's leading causes of mortality, accounting for over 18 million deaths a year. A team of KIT researchers has now identified a new cell type in blood vessels responsible for vascular growth.
When someone has a heart attack or a stroke, specialized care can give them the best chance of surviving.
Cedars-Sinai Cancer investigators attending the American Association for Cancer Research Annual Meeting April 5-10 in San Diego are available to comment on scientific advances being presented throughout the conference.
B-type natriuretic peptide (BNP) plays a key role in chronic itch severity and can help to identify certain types of itch with a simple blood test, according to a new study led by Gil Yosipovitch, M.D., director of the Miami Itch Center, and Santosh Mishra, Ph.D., a neuroscientist and associate professor at the North Carolina State College of Veterinary Medicine.
While CRISPR has shown immense promise as a next-generation therapeutic tool, the gene editing technology’s edits are still imperfect. Researchers have developed a new system to test and analyze CRISPR-based DNA repair and related risks from unintended but harmful “bystander” edits.
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health have appointed Nirag Jhala, MD, as chief of the Division of Oncologic Pathology at New Jersey’s leading cancer program and only National Cancer Institute (NCI)-designated Comprehensive Cancer Center.
Imagine being able to count the different types of blood cells being formed inside the tiny bones of a mouse and pinpointing the strings and clusters of cells within the bone marrow that are responsible for producing specific types of blood cells.
A transformative gift to expand research and breakthrough therapies, an upcoming conference on managing neuroendocrine tumors, FDA approval of Imetelstat for patients with anemia from myelodysplastic syndromes and a researcher advocating for making bereavement care a public health priority are all included in this month’s tip sheet from Sylvester Comprehensive Cancer Center.
Patients with some types of lymphoma that become resistant to standard treatments may benefit from a therapy that University of Wisconsin–Madison researchers are evaluating after they discovered a key process that fuels the blood cancers’ resistance to current drugs.
For the fourth consecutive year, the Blood and Marrow Transplant Program in the Division of Hematology and Cellular Therapy at Cedars-Sinai has achieved higher than expected survival rates in patients receiving allogeneic stem cell transplantation, according to a recent report from the Center for International Blood and Marrow Transplant Research.
A blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detected colorectal cancer in 83% of people confirmed to have the disease, according to a study published March 14 in the New England Journal of Medicine.
A team of investigators from the UCLA Health Jonsson Comprehensive Cancer and the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute was awarded a $3.2 million grant from the National Institutes of Health to identify new ways to prevent and overcome treatment resistance to targeted therapy in patients with all sub-types of cutaneous melanoma, an aggressive form of skin cancer.
As we age, our hematopoietic (blood-forming) stem cells (HSCs) become less able to produce new red and white blood cells and other vital blood components—contributing to chronic inflammation and accelerating the onset of blood cancers and degenerative diseases.
Reuben Kapur, director of the Herman B Wells Center for Pediatric Research at the Indiana University School of Medicine, is working to discover new treatments that will improve patient care.
St. Jude Children’s Research Hospital scientists showed inhibiting both JAK1 and JAK2 proteins improved hemophagocytic lymphohistiocytosis in models of the inflammatory syndrome.
Researcher Tim Randolph, Ph.D., professor of clinical health sciences at Saint Louis University, has been named a Senior Member of the National Academy of Inventors.
One in four older adults take aspirin at least three times a week, mostly in hopes of preventing heart attacks and strokes, a new poll shows. But many people aged 50 to 80 who said they take aspirin may not need to because hey don’t have a history of cardiovascular disease.
People with cancer have different amounts of a type of repetitive DNA — called Alu elements — than people without cancer.
Children’s Hospital Los Angeles has received a multi-year $6 million award from the California Institute for Regenerative Medicine (CIRM) to develop innovative stem cell approaches to treat children and adolescents with recurrent solid tumors. The Cancer and Blood Disease Institute (CBDI) is a recognized leader in pediatric cancer care and research.
Anthropologists working with a hematologist colleague have developed a way to detect anemia in archaeological remains by using microscopic patterns in the structures of bones.
The National Institutes of Health (NIH) has awarded researchers at Case Western Reserve University a grant to begin studying the possible long-term health effects of exposure to hazardous chemicals from the East Palestine, Ohio, train derailment.
A passionate plea for the re-establishment of Canada's health coalition focused on hypertension prevention and control appears as an editorial in the Canadian Journal of Cardiology, published by Elsevier.
Cedars-Sinai investigators have detailed a new way that bacteria use iron to cooperate and resist antibiotic treatment. The study, led by the Cedars-Sinai departments of Biomedical Sciences and Pathology and Laboratory Medicine, is published in the peer-reviewed journal Nature Microbiology and is the first to show this type of antibiotic cross-protection.
Blood vessels constitute a closed pipe system distributed throughout the body, transporting blood from the heart to other organs and delivering metabolic waste products back to the lungs and kidneys. Changes in blood vessels are related to
BACKGROUNDIn vitro expansion to increase numbers of hematopoietic stem cells (HSCs) in cord blood could improve clinical efficacy of this vital resource. Nicotinamide (NAM) can promote HSC expansion ex vivo, but its effect on hematopoietic
About eight million people live with Type 1 diabetes (T1D) worldwide, a chronic autoimmune condition in which the body attacks and destroys its own insulin-producing β-cells (pronounced “beta”) in the pancreas, leading to a lack of insulin and inability to regulate blood sugar. It’s not known why the body suddenly perceives its own β-cells as the enemy; some lines of evidence suggest environmental factors such as viral infections may trigger the onset of T1D, others suggest genetics may also play some role. Groundbreaking research by investigators at Joslin Diabetes Center sheds new light on the specific changes β-cells go through at the onset of T1D. Their findings—published in Nature Cell Biology—offer new avenues for targeted interventions for the chronic autoimmune condition.
A gut microbial metabolite called 2-methylbutyrylcarnitine (2MBC) plays a role in exacerbating thrombosis -- the formation of blood clots – researchers report February 23rd in the journal Cell Metabolism.
Only six millimeters in length, black flies (Simuliidae) may look harmless like house flies, but their bites can be very unpleasant.
Certain genes associated with hypertension affect blood pressure from early in life, and they increase the risk of cardiovascular disease as you get older. However, you can do something about it.
Results of 16-Center REVIVE trial published in The New England Journal of Medicine
SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression. New research shows that in Long COVID patients, IFN-y production persists until symptoms improve, highlighting a potential biomarker and a target for therapies.
A new analysis method can detect pathogens in blood samples faster and more accurately than blood cultures, which are the current state of the art for infection diagnosis. The new method, called digital DNA melting analysis, can produce results in under six hours, whereas culture typically requires 15 hours to several days, depending on the pathogen.
Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, is one of the first centers nationwide to offer a newly approved cell-based immunotherapy that targets melanoma.
A first-of-its-kind cellular immunotherapy pioneered at Moffitt Cancer Center has received approval from the Food and Drug Administration and is now available for patients with advanced melanoma. Lifileucel is the first tumor-infiltrating lymphocyte therapy, or TIL, approved for solid tumors.
The qualities of flowing blood, or hemodynamics, hold important insights into vascular diseases, but technological limitations have largely kept measurements of these properties out of reach in the clinic. Now, there may be a potential solution on the horizon.
A new study published by Nutrients reports that consuming 100% orange juice prior to a meal, when compared to sugar-sweetened, orange-flavored drinks, suppresses food intake at the next meal and results in lower daily blood glucose concentrations in healthy, normal-weight adults.1
The discovery of a pair of genes that work in perfect harmony to protect male fertility, could provide new insights into some unexplained cases of the most severe form of infertility, research suggests.
White blood cells known as neutrophils feature a nucleus that is structured strikingly different than most nuclei. These unique shapes permit neutrophils to travel all over the body to combat invading pathogens.
A group of international mycology experts led by Professor Dr Oliver A. Cornely at the University of Cologne has jointly drafted a guideline for the diagnosis and treatment of cryptococcosis, which aims at improving infection management and thus the survival rate of patients.
Below are some of the latest research and features on this growing population of older adults in the Seniors channel on Newswise.
Chula researchers have developed a remarkable wireless hepatitis B virus test kit to screen for infection and collect data for an online database that’s fast and complete in one step.
Using the results of a standard blood test and an online tool, you can find out if you are at increased risk of having a heart attack within six months.
Labeling cancer cells with genetic barcodes “In ReSisTrace, we label cancer cells uniquely with genetic barcodes and allow them to divide once, so that we get two identical sister cells that share the same barcode.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
